京東(09618.HK)擬分拆京東健康獨立上市 指中期經調整純利3.7億人幣
京東(09618.HK)公布,其接獲京東健康通知,京東健康已就擬議分拆向香港聯交所遞交聆訊後資料集,以供於香港聯交所網站發佈。擬議分拆細節尚未落實,公司會在適當時就擬議分拆另行公告。
京東健康發布更新版招股書顯示,2019年全年收入108.42億元人民幣(下同);截至2020年6月30日止六個月中期收入87.77億元,按年增長76%。
受到A輪可轉換優先股的公允價值變動的影響,公司在報告期內的利潤有所波動,如果剔除這部分非運營相關的因素,非按照《國際財務報告準則》呈列,公司從2017年至2019年的淨利潤分別為2.09億元、2.48億元、3.44億元,2020年上半年淨利潤為3.71億元,盈利能力持續提升。
此外,京東健康於2017年、2018年及2019年以及截至2020年6月30日止十二個月,分別擁有4,390萬、5,050萬、5,610萬、7,250萬個年活躍用戶,年活躍用戶持續增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.